Robert E. Martell

2.8k total citations
97 papers, 2.1k citations indexed

About

Robert E. Martell is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert E. Martell has authored 97 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 46 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert E. Martell's work include Histone Deacetylase Inhibitors Research (25 papers), Protein Degradation and Inhibitors (18 papers) and Lymphoma Diagnosis and Treatment (12 papers). Robert E. Martell is often cited by papers focused on Histone Deacetylase Inhibitors Research (25 papers), Protein Degradation and Inhibitors (18 papers) and Lymphoma Diagnosis and Treatment (12 papers). Robert E. Martell collaborates with scholars based in United States, Canada and United Kingdom. Robert E. Martell's co-authors include Jeffrey M. Besterman, Zuomei Li, Gregory K. Reid, Robert U. Simpson, Marja Dubay, Anas Younes, Ann Kalita, Claire Bonfils, Jennifer M. Taylor and Eric Laille and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Robert E. Martell

97 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Martell United States 25 1.3k 746 373 277 227 97 2.1k
Roger Strair United States 21 783 0.6× 422 0.6× 325 0.9× 180 0.6× 203 0.9× 68 1.6k
Donna Headlee United States 24 1.5k 1.1× 1.1k 1.4× 210 0.6× 236 0.9× 330 1.5× 34 2.7k
Kiyoshi Okamoto Japan 15 611 0.5× 514 0.7× 200 0.5× 161 0.6× 100 0.4× 55 1.7k
Maria Luisa Veronese United States 18 969 0.7× 678 0.9× 262 0.7× 136 0.5× 107 0.5× 35 1.8k
Benjamin Mow Singapore 11 567 0.4× 673 0.9× 368 1.0× 118 0.4× 302 1.3× 17 1.4k
Mark Catherwood United Kingdom 21 444 0.3× 287 0.4× 385 1.0× 433 1.6× 225 1.0× 53 1.3k
Stefan Balabanov Germany 32 1.4k 1.1× 372 0.5× 150 0.4× 449 1.6× 316 1.4× 99 2.8k
Lorelei J. Hanson United States 15 1.1k 0.9× 971 1.3× 224 0.6× 86 0.3× 79 0.3× 20 1.8k
Luna Musib United States 24 1.4k 1.1× 952 1.3× 405 1.1× 751 2.7× 104 0.5× 77 2.6k
Toshiyuki Kitano Japan 18 782 0.6× 536 0.7× 111 0.3× 86 0.3× 234 1.0× 70 1.6k

Countries citing papers authored by Robert E. Martell

Since Specialization
Citations

This map shows the geographic impact of Robert E. Martell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Martell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Martell more than expected).

Fields of papers citing papers by Robert E. Martell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Martell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Martell. The network helps show where Robert E. Martell may publish in the future.

Co-authorship network of co-authors of Robert E. Martell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Martell. A scholar is included among the top collaborators of Robert E. Martell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Martell. Robert E. Martell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noelle, Randolph J., J. Louise Lines, Lionel D. Lewis, et al.. (2023). Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights. Frontiers in Oncology. 13. 1225081–1225081. 12 indexed citations
2.
3.
4.
Zauderer, Marjorie G., Joshua Brody, Thomas U. Marron, et al.. (2019). P2.06-07 Phase 1 Study of CA-170: First-in-Class Small Molecule Targeting VISTA/PD-L1 in Patients with Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 14(10). S757–S758. 7 indexed citations
5.
Grimm, Elizabeth A., et al.. (2019). A phase I delayed-start, randomized and pharmacodynamic study of metformin and chemotherapy in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 84(6). 1323–1331. 16 indexed citations
6.
Paulus, Jessica K., et al.. (2016). Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention. 25(10). 1418–1425. 28 indexed citations
7.
Tryfonidis, Konstantinos, Jan Bogaerts, Robert E. Martell, et al.. (2014). A phase III randomized trial of niraparib versus physician’s choice in previously treated, HER2-negative, germline-BRCA mutated breast cancer patients: Intergroup study EORTC-1307-BCG and BIG5-13.. Journal of Clinical Oncology. 32(15_suppl). TPS659–TPS659. 8 indexed citations
8.
Adams‐Campbell, Lucile L., Rowan T. Chlebowski, Marc J. Gunter, et al.. (2013). Diabetes, metformin use, and colorectal cancer survival in postmenopausal women. Cancer Epidemiology. 37(5). 742–749. 50 indexed citations
9.
Younes, Anas, Yasuhiro Oki, R. Gregory Bociek, et al.. (2011). Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial. The Lancet Oncology. 12(13). 1222–1228. 156 indexed citations
10.
Blum, Kristie A., Richard van der Jagt, Joseph Brandwein, et al.. (2009). Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia. British Journal of Haematology. 147(4). 507–514. 94 indexed citations
11.
Liu, Jianhong, Claire Bonfils, Marja Dubay, et al.. (2008). Induction of an anti-angiogenesis factor, Thrombospondin 1 (TSP-1), by a novel histone deacetylase inhibitor, MGCD0103, in human cancer cells in vitro and in vivo. Cancer Research. 68. 739–739. 1 indexed citations
12.
Bonfils, Claire, Ann Kalita, Marja Dubay, et al.. (2008). Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay. Clinical Cancer Research. 14(11). 3441–3449. 81 indexed citations
13.
Heath, Elisabeth I., Keith C. Bible, Robert E. Martell, Daniel C. Adelman, & Patricia LoRusso. (2007). A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors. Investigational New Drugs. 26(1). 59–65. 89 indexed citations
14.
Bailey, Howard H., Dona Alberti, James P. Thomas, et al.. (2007). Phase I Trial of Weekly Paclitaxel and BMS-214662 in Patients with Advanced Solid Tumors. Clinical Cancer Research. 13(12). 3623–3629. 14 indexed citations
15.
Martell, Robert E., Joseph R. Nevins, & Bruce A. Sullenger. (2002). Optimizing Aptamer Activity for Gene Therapy Applications Using Expression Cassette SELEX. Molecular Therapy. 6(1). 30–34. 61 indexed citations
16.
Cassell, Delanie J., Shurjeel Choudhri, Rachel Humphrey, et al.. (2002). Therapeutic Enhancement of IL-2 Through Molecular Design. Current Pharmaceutical Design. 8(24). 2171–2183. 12 indexed citations
17.
Farb, Roderick M., et al.. (2001). Reconstitution of DNA Synthetic Capacity in Senescent Normal Human Fibroblasts by Expressing Cellular Factors E2F and Mdm2. Experimental Cell Research. 270(2). 268–276. 5 indexed citations
18.
Martell, Robert E. & Raymond W. Ruddon. (1990). Patterns of Human Chorionic Gonadotropin Expression in Untreated and 8-Bromoadenosine-Treated JAR Choriocarcinoma Cells*. Endocrinology. 126(5). 2757–2764. 13 indexed citations
19.
Strawn, Laurie M., Robert E. Martell, Robert U. Simpson, Karen L. Leach, & Raymond E. Counsell. (1989). Iodoaryl analogs of dioctanoylglycerol and 1-oleoyl-2-acetylglycerol as probes for protein kinase C. Journal of Medicinal Chemistry. 32(9). 2104–2110. 10 indexed citations
20.
Strawn, Laurie M., Robert E. Martell, Robert U. Simpson, Karen L. Leach, & Raymond E. Counsell. (1989). Synthesis and evaluation of iodinated analogs of diacylglycerols as potential probes for protein kinase C. Journal of Medicinal Chemistry. 32(3). 643–648. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger Strair Breakdown of academic impact, for papers by Donna Headlee Breakdown of academic impact, for papers by Kiyoshi Okamoto Breakdown of academic impact, for papers by Maria Luisa Veronese Breakdown of academic impact, for papers by Benjamin Mow Breakdown of academic impact, for papers by Mark Catherwood Breakdown of academic impact, for papers by Stefan Balabanov Breakdown of academic impact, for papers by Lorelei J. Hanson Breakdown of academic impact, for papers by Luna Musib Breakdown of academic impact, for papers by Toshiyuki Kitano
Rankless by CCL
2026